Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide.

Chang J, Varghese DS, Gillam MC, Peyton M, Modi B, Schiltz RL, Girard L, Martinez ED.

Br J Cancer. 2012 Jan 3;106(1):116-25. doi: 10.1038/bjc.2011.532. Epub 2011 Dec 8.

2.

Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.

Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA.

Urol Oncol. 2013 Nov;31(8):1770-9. doi: 10.1016/j.urolonc.2012.06.015. Epub 2012 Sep 1.

PMID:
22944197
3.

Histone deacetylase as a new target for cancer chemotherapy.

Yoshida M, Furumai R, Nishiyama M, Komatsu Y, Nishino N, Horinouchi S.

Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S20-6. Review.

PMID:
11587361
5.

HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).

Mehdi O, Françoise S, Sofia CL, Urs G, Kevin Z, Bernard S, Igor S, Anabela CD, Dominique L, Eric M, Ali O.

Pancreatology. 2012 Mar-Apr;12(2):146-55. doi: 10.1016/j.pan.2012.02.013. Epub 2012 Feb 25.

PMID:
22487525
7.

Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.

Frønsdal K, Saatcioglu F.

Prostate. 2005 Feb 15;62(3):299-306.

PMID:
15389787
8.

Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.

El-Awady RA, Hersi F, Al-Tunaiji H, Saleh EM, Abdel-Wahab AH, Al Homssi A, Suhail M, El-Serafi A, Al-Tel T.

Cancer Biol Ther. 2015;16(7):1056-70. doi: 10.1080/15384047.2015.1046023.

9.

The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.

Zhu WG, Otterson GA.

Curr Med Chem Anticancer Agents. 2003 May;3(3):187-99. Review.

PMID:
12769777
10.

Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.

Ahrens TD, Timme S, Hoeppner J, Ostendorp J, Hembach S, Follo M, Hopt UT, Werner M, Busch H, Boerries M, Lassmann S.

Epigenetics. 2015;10(5):431-45. doi: 10.1080/15592294.2015.1039216.

11.

Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.

Zhang YW, Staal B, Dykema KJ, Furge KA, Vande Woude GF.

PLoS One. 2012;7(6):e38955. doi: 10.1371/journal.pone.0038955. Epub 2012 Jun 12.

12.

Identification of novel isoform-selective inhibitors within class I histone deacetylases.

Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, de los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M.

J Pharmacol Exp Ther. 2003 Nov;307(2):720-8. Epub 2003 Sep 15.

13.

Inhibition of Histone Deacetylases Enhances the Osteogenic Differentiation of Human Periodontal Ligament Cells.

Huynh NC, Everts V, Pavasant P, Ampornaramveth RS.

J Cell Biochem. 2016 Jun;117(6):1384-95. doi: 10.1002/jcb.25429. Epub 2015 Nov 26.

PMID:
27043246
14.

Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.

Duo J, Ma Y, Wang G, Han X, Zhang C.

DNA Cell Biol. 2013 Apr;32(4):156-64. doi: 10.1089/dna.2012.1926. Epub 2013 Mar 1.

PMID:
23451817
15.

Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B.

Liu N, Zhao LJ, Li XP, Wang JL, Chai GL, Wei LH.

Chin Med J (Engl). 2012 Sep;125(18):3273-8.

PMID:
22964322
16.

Troglitazone inhibits histone deacetylase activity in breast cancer cells.

Davies GF, Ross AR, Arnason TG, Juurlink BH, Harkness TA.

Cancer Lett. 2010 Feb 28;288(2):236-50. doi: 10.1016/j.canlet.2009.07.011. Epub 2009 Aug 20.

PMID:
19699029
17.

Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53.

Kim IA, Shin JH, Kim IH, Kim JH, Kim JS, Wu HG, Chie EK, Ha SW, Park CI, Kao GD.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):940-9.

18.

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.

Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M, Marcucci G.

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2390-8.

PMID:
12766035
19.

Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.

Wu LP, Wang X, Li L, Zhao Y, Lu S, Yu Y, Zhou W, Liu X, Yang J, Zheng Z, Zhang H, Feng J, Yang Y, Wang H, Zhu WG.

Mol Cell Biol. 2008 May;28(10):3219-35. doi: 10.1128/MCB.01516-07. Epub 2008 Mar 10.

20.

Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.

Chiba T, Yokosuka O, Fukai K, Kojima H, Tada M, Arai M, Imazeki F, Saisho H.

Oncology. 2004;66(6):481-91.

PMID:
15452378

Supplemental Content

Support Center